rs1057519749
|
|
G |
0.700 |
GeneticVariation |
CLINVAR |
RUNX1 mutation associated with clonal evolution in relapsed pediatric acute myeloid leukemia with t(16;21)(p11;q22).
|
24374719 |
2014 |
rs1057519749
|
|
G |
0.700 |
GeneticVariation |
CLINVAR |
Clinical impact of gene mutations and lesions detected by SNP-array karyotyping in acute myeloid leukemia patients in the context of gemtuzumab ozogamicin treatment: results of the ALFA-0701 trial.
|
24659740 |
2014 |
rs1057519749
|
|
A |
0.700 |
GeneticVariation |
CLINVAR |
Clinical impact of gene mutations and lesions detected by SNP-array karyotyping in acute myeloid leukemia patients in the context of gemtuzumab ozogamicin treatment: results of the ALFA-0701 trial.
|
24659740 |
2014 |
rs1057519749
|
|
G |
0.700 |
GeneticVariation |
CLINVAR |
Minimal residual disease monitoring in t(8;21) acute myeloid leukemia based on RUNX1-RUNX1T1 fusion quantification on genomic DNA.
|
24616160 |
2014 |
rs1057519749
|
|
A |
0.700 |
GeneticVariation |
CLINVAR |
RUNX1 mutation associated with clonal evolution in relapsed pediatric acute myeloid leukemia with t(16;21)(p11;q22).
|
24374719 |
2014 |
rs1057519749
|
|
A |
0.700 |
GeneticVariation |
CLINVAR |
Minimal residual disease monitoring in t(8;21) acute myeloid leukemia based on RUNX1-RUNX1T1 fusion quantification on genomic DNA.
|
24616160 |
2014 |
rs1057519750
|
|
T |
0.700 |
GeneticVariation |
CLINVAR |
Clinical impact of gene mutations and lesions detected by SNP-array karyotyping in acute myeloid leukemia patients in the context of gemtuzumab ozogamicin treatment: results of the ALFA-0701 trial.
|
24659740 |
2014 |
rs1057519750
|
|
T |
0.700 |
GeneticVariation |
CLINVAR |
High frequency of RUNX1 biallelic alteration in acute myeloid leukemia secondary to familial platelet disorder.
|
19357396 |
2009 |
rs1057519748
|
|
A |
0.700 |
GeneticVariation |
CLINVAR |
Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia.
|
10508512 |
1999 |
rs2249650
|
|
|
0.010 |
GeneticVariation |
BEFREE |
To sum up, rs2268276 and especially rs2249650 may be qualified as new acute myeloid leukemia susceptibility-associated SNPs.
|
26374622 |
2016 |
rs2268276
|
|
|
0.010 |
GeneticVariation |
BEFREE |
To sum up, rs2268276 and especially rs2249650 may be qualified as new acute myeloid leukemia susceptibility-associated SNPs.
|
26374622 |
2016 |
rs757412228
|
|
|
0.010 |
GeneticVariation |
BEFREE |
We identified TET2 and PTPN11 mutations in both mouse and human AML and then demonstrated the ability of Tet2 loss and PTPN11 D61Y to initiate leukemogenesis in concert with expression of AML1-ETO in vivo.
|
26666262 |
2016 |
rs1482518887
|
|
|
0.010 |
GeneticVariation |
BEFREE |
KRAS (G12D) cooperates with AML1/ETO to initiate a mouse model mimicking human acute myeloid leukemia.
|
24480914 |
2014 |
rs74315450
|
|
|
0.010 |
GeneticVariation |
BEFREE |
RUNX1, which regulates a gene for hematopoiesis, is frequently mutated in AML and, in this study, one out of three patients showed the mutation R174Q in RUNX1.
|
20694842 |
2010 |